Sonic Healthcare Ltd higher Tuesday, outperforms the Health Care sector
Here is the latest company close update for Sonic Healthcare Ltd, SHL.
Here is the latest company close update for Sonic Healthcare Ltd, SHL.
The $12bn Sonic Healthcare has been talking about further acquisitions for years, but one of its next big Australia deals could be just around the corner.
In a subdued session, Tuesday’s trading gave back a portion of Monday’s rally.
The pathology and radiology provider has cut its annual profit forecast by more than $100m, with inflation and currency headwinds taking their toll.
In Part 2 of our look at the ASX’s dominant pathology stocks, Morningstar considers the second-largest operation, Healius and areas it can finetune.
As the pandemic faded, so did investors’ thirst for now-undervalued ASX pathology stocks, says Morningstar, as it puts Sonic under the microscope.
The ASX-listed pathology group has bought Dr Risch as it looks to expand its presence in Switzerland after interim profit dived 47 per cent.
A drop in ‘Covid revenue’ punched a hole in Sonic Healthcare’s results but it called out AI as part of a $350m growth strategy.
Collins Foods jumps on eight-month high after earnings beat. Iron ore in biggest jump since May. Bega to sell $115m Port Melbourne site. Medibank falls on APRA’s $250m hit.
Small cap health stocks commonly don’t pay dividends. But these ASX players have been handing out – not burning through – cash.
Sonic Healthcare says full-year profits fell because patients stayed away due to COVID restrictions and infection worries.
Original URL: https://www.theaustralian.com.au/topics/sonic-healthcare/page/2